Suchergebnisse - "Sessa, C"

PubPharm (30)

1

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer : a randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Pignata, S. | Lorusso, D. | Joly, F. | +62

2

Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Stathis, A. | Hess, D. | von Moos, R. | +13

3

Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Stathis, A. | Hess, D. | von Moos, R. | +12

4

Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Stathis, A. | Hess, D. | von Moos, R. | +12

5

Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Stathis, A. | Hess, D. | von Moos, R. | +12

6

Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2010

von Sessa, C. | Tosi, D. | Viganò, L. | +12

7

Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumours

enthalten in: European journal of cancer (Oxford, England : 1990) | 2008

von Cresta, S. | Sessa, C. | Catapano, C. | +10

8

Randomized single-agents trials in recurrent epithelial ovarian cancer

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2005

von Sessa, C. | Marsoni, S.

9

Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2002

von Sessa, C. | Cuvier, C. | Caldiera, S. | +8

10

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2001

von Crivellari, D. | Pagani, O. | Veronesi, A. | +11